Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 3
1917 3
1918 2
1919 1
1949 1
1950 1
1951 1
1952 2
1953 3
1954 2
1955 1
1957 2
1958 1
1959 1
1960 1
1961 9
1962 10
1963 11
1964 21
1965 16
1966 21
1967 25
1968 35
1969 41
1970 38
1971 32
1972 23
1973 23
1974 47
1975 33
1976 28
1977 44
1978 38
1979 38
1980 51
1981 61
1982 72
1983 80
1984 75
1985 93
1986 90
1987 83
1988 93
1989 104
1990 125
1991 126
1992 133
1993 131
1994 120
1995 157
1996 200
1997 188
1998 199
1999 232
2000 177
2001 200
2002 183
2003 247
2004 247
2005 248
2006 252
2007 244
2008 247
2009 268
2010 314
2011 329
2012 365
2013 317
2014 359
2015 365
2016 370
2017 381
2018 365
2019 394
2020 455
2021 482
2022 314
Text availability
Article attribute
Article type
Publication date

Search Results

9,243 results
Results by year
Filters applied: . Clear all
Page 1
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, Felip E, Broderick SR, Brahmer JR, Swanson SJ, Kerr K, Wang C, Ciuleanu TE, Saylors GB, Tanaka F, Ito H, Chen KN, Liberman M, Vokes EE, Taube JM, Dorange C, Cai J, Fiore J, Jarkowski A, Balli D, Sausen M, Pandya D, Calvet CY, Girard N; CheckMate 816 Investigators. Forde PM, et al. Among authors: ito h. N Engl J Med. 2022 May 26;386(21):1973-1985. doi: 10.1056/NEJMoa2202170. Epub 2022 Apr 11. N Engl J Med. 2022. PMID: 35403841 Clinical Trial.
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, Aoki T, Okami J, Yoshino I, Ito H, Okumura N, Yamaguchi M, Ikeda N, Wakabayashi M, Nakamura K, Fukuda H, Nakamura S, Mitsudomi T, Watanabe SI, Asamura H; West Japan Oncology Group and Japan Clinical Oncology Group. Saji H, et al. Among authors: ito h. Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3. Lancet. 2022. PMID: 35461558 Clinical Trial.
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure.
Tsutsui H, Ide T, Ito H, Kihara Y, Kinugawa K, Kinugawa S, Makaya M, Murohara T, Node K, Saito Y, Sakata Y, Shimizu W, Yamamoto K, Bando Y, Iwasaki YK, Kinugasa Y, Mizote I, Nakagawa H, Oishi S, Okada A, Tanaka A, Akasaka T, Ono M, Kimura T, Kosaka S, Kosuge M, Momomura SI. Tsutsui H, et al. Among authors: ito h. J Card Fail. 2021 Dec;27(12):1404-1444. doi: 10.1016/j.cardfail.2021.04.023. Epub 2021 Sep 28. J Card Fail. 2021. PMID: 34600838 Review. No abstract available.
Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction - Results From the PARALLEL-HF Study.
Tsutsui H, Momomura SI, Saito Y, Ito H, Yamamoto K, Sakata Y, Desai AS, Ohishi T, Iimori T, Kitamura T, Guo W; PARALLEL-HF Investigators. Tsutsui H, et al. Among authors: ito h. Circ J. 2021 Apr 23;85(5):584-594. doi: 10.1253/circj.CJ-20-0854. Epub 2021 Mar 16. Circ J. 2021. PMID: 33731544 Free article. Clinical Trial.
Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell-mediated inflammation in the skin.
Takahashi H, Nomura H, Iriki H, Kubo A, Isami K, Mikami Y, Mukai M, Sasaki T, Yamagami J, Kudoh J, Ito H, Kamata A, Kurebayashi Y, Yoshida H, Yoshimura A, Sun HW, Suematsu M, O'Shea JJ, Kanno Y, Amagai M. Takahashi H, et al. Among authors: ito h. Sci Immunol. 2021 Oct 15;6(64):eabb6444. doi: 10.1126/sciimmunol.abb6444. Epub 2021 Oct 8. Sci Immunol. 2021. PMID: 34623903
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. Oki R, et al. Among authors: ito h. JAMA Neurol. 2022 Jun 1;79(6):575-583. doi: 10.1001/jamaneurol.2022.0901. JAMA Neurol. 2022. PMID: 35532908 Clinical Trial.
Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.
Momozawa Y, Sasai R, Usui Y, Shiraishi K, Iwasaki Y, Taniyama Y, Parsons MT, Mizukami K, Sekine Y, Hirata M, Kamatani Y, Endo M, Inai C, Takata S, Ito H, Kohno T, Matsuda K, Nakamura S, Sugano K, Yoshida T, Nakagawa H, Matsuo K, Murakami Y, Spurdle AB, Kubo M. Momozawa Y, et al. Among authors: ito h. JAMA Oncol. 2022 Jun 1;8(6):871-878. doi: 10.1001/jamaoncol.2022.0476. JAMA Oncol. 2022. PMID: 35420638 Free PMC article.
Upadacitinib and pulmonary actinomycosis.
Ito H. Ito H. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e1071. doi: 10.1097/MEG.0000000000001899. Eur J Gastroenterol Hepatol. 2021. PMID: 35048664 No abstract available.
Total Synthesis of ent-Callilongisin B.
Kamiya A, Kawamoto Y, Kobayashi T, Ito H. Kamiya A, et al. Among authors: ito h. Org Lett. 2021 Sep 3;23(17):6916-6918. doi: 10.1021/acs.orglett.1c02473. Epub 2021 Aug 23. Org Lett. 2021. PMID: 34424723
9,243 results